Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.42 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.41 |
| ▸ | TPMT | P51580 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL28028999 | 0.97 | ALDH1A1 (0.42) | ALDH1A1MAPTMAPK1TAS1R3TAS1R1 | |
| Biphenyl SCHEMBL27683906 | 0.83 | SMN1; SMN2 (0.43) | ALDH1A1MAPTLMNAKMT2AMEN1 | |
| Bicarbonate SCHEMBL7975060 | 0.81 | KDM4E (0.53) | ALDH1A1MAPTMAPK1TAS1R3TAS1R1 | |
| SCHEMBL31162472 | 0.81 | TAS1R3 (0.41) | ALDH1A1MAPTMAPK1TAS1R3TAS1R1 | |
| SCHEMBL22109937 | 0.80 | HPGD (0.47) | ALDH1A1MAPTMAPK1TAS1R3TAS1R1 | |
| SCHEMBL6666412 | 0.80 | HPGD (0.52) | ALDH1A1MAPTMAPK1TAS1R3TAS1R1 | |
| SCHEMBL29565638 | 0.78 | TAS1R3 (0.42) | ALDH1A1MAPTMAPK1TAS1R3TAS1R1 | |
| SCHEMBL21870 | 0.78 | KDM4E (0.55) | ALDH1A1MAPTMAPK1TAS1R3TAS1R1 | |
| SCHEMBL377596 | 0.78 | KDM4E (0.55) | ALDH1A1MAPTMAPK1TAS1R3TAS1R1 | |
| SCHEMBL698413 | 0.78 | KDM4E (0.46) | ALDH1A1MAPTMAPK1TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110982157-A | Low-odor rapid UV-LED ultraviolet light crosslinked polyethylene insulating material and preparation method thereof | 上海新上化高分子材料有限公司 | 2020-04-10 | — | — | CN | claimed |
| CN-108948393-A | A kind of antistatic UV hardening bath and its preparation and application method | 无锡卓宇兴盛光电科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-107858081-A | A kind of uV curable showering low luster coating composition and preparation method thereof | 苏州市明大高分子科技材料有限公司 | 2018-03-30 | — | — | CN | claimed |
| CN-106751349-A | A kind of radical cation hybrid UV-curing resin and preparation method and application | 中山大简高分子材料有限公司 | 2017-05-31 | — | — | CN | claimed |
| EP-0343911-A2 | Cycloalkyl-substituted glutaramide diuretic agents | Pfizer Limited (GB) | 1989-11-29 | — | — | EP | claimed |
| WO-2022065424-A1 | CARCINOSTATIC AGENT, CARCINOGENESIS INHIBITOR AND LIFE-PROLONGING AGENT, COMPRISING NOVEL COMPOUND WITH MTORC1 INHIBITORY EFFECT | 国立研究開発法人理化学研究所 | 2022-03-31 | — | — | WO | disclosed |
| EP-3564232-B1 | BMP-SIGNAL-INHIBITING COMPOUND | RIKEN (JP) | 2022-01-26 | — | — | EP | disclosed |
| US-10954216-B2 | BMP-signal-inhibiting compound | RIKEN (JP) | 2021-03-23 | — | — | US | disclosed |
| CN-110982157-A | Low-odor rapid UV-LED ultraviolet light crosslinked polyethylene insulating material and preparation method thereof | 上海新上化高分子材料有限公司 | 2020-04-10 | — | — | CN | disclosed |
| CN-110431189-A | addition-curable silicone composition | SHINETSU CHEMICAL CO | 2019-11-08 | — | — | CN | disclosed |
| US-20190337926-A1 | BMP-SIGNAL-INHIBITING COMPOUND | RIKEN (JP) | 2019-11-07 | — | — | US | disclosed |
| EP-3564232-A1 | BMP-SIGNAL-INHIBITING COMPOUND | Riken (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-0214708-B1 | GRISEOLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE | SANKYO COMPANY LIMITED (JP) | 1989-12-13 | — | — | EP | disclosed |
| EP-0319316-A2 | Griseolic acid monoesters, their preparation and use | SANKYO COMPANY LIMITED (JP) | 1989-06-07 | — | — | EP | disclosed |
| EP-0319050-A2 | Griseolic acid derivatives, their preparation and their use | SANKYO COMPANY LIMITED (JP) | 1989-06-07 | — | — | EP | disclosed |
| EP-0318060-A2 | Griseolic acid derivatives, their preparation and their use | Sankyo Company Limited (JP) | 1989-05-31 | — | — | EP | disclosed |
| EP-0251827-A2 | New cyclic ether derivatives, their preparation and their use | Sankyo Company Limited (JP) | 1988-01-07 | — | — | EP | disclosed |
| EP-0214708-A2 | Griseolic acid derivatives, their preparation and their use | SANKYO COMPANY LIMITED (JP) | 1987-03-18 | — | — | EP | disclosed |
| EP-0180188-A2 | A composition for increasing the anti-cancer activity of an anti-cancer compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-07 | — | — | EP | disclosed |
| US-3936462-A | CNS DEPRESSANT, ANALGESIC | STERLING DRUG INC. (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10954216-B2 | BMP-signal-inhibiting compound | BMP1, BMP2, BMP4 | ALDH1A1 4324/4885MAPT 4782/4885MAPK1 72/4885 |
| US-20190337926-A1 | BMP-SIGNAL-INHIBITING COMPOUND | BMP1, BMP2, BMPR2 | ALDH1A1 4102/4885MAPT 4243/4885MAPK1 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.